Autolus Therapeutics (AUTL) Intangibles (2018 - 2025)

Autolus Therapeutics (AUTL) has reported Intangibles for 7 consecutive years, with $19.8 million the latest figure, recorded in Q4 2025.

• Quarterly Intangibles rose 60.1% year-over-year to $19.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.8 million (up 60.1% YoY) and the FY2025 annual result came in at $19.8 million, up 60.1% from the prior year.
• Intangibles declined to $19.8 million in Q4 2025 per AUTL's latest filing, from $20.3 million in the prior quarter.
• Over the last five years, Intangibles for AUTL reached as high as $20.3 million in Q3 2025 and fell as low as $8000.0 in Q3 2022.
• A 4-year average of $6.5 million and a median of $123500.0 in 2021 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles plunged 90.8% — and 2025, when it soared 60.1%.
• Year by year, Intangibles stood at $65000.0 in 2021, then plunged by 87.69% to $8000.0 in 2022, then soared by 154562.5% to $12.4 million in 2024, then surged by 60.1% to $19.8 million in 2025.
• According to Business Quant data, Intangibles over the past three periods registered $19.8 million, $20.3 million, and $12.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.